(3-((4,5-Dihydrothiazol-2-yl)carbamoyl)phenyl)boronic acid, 98%, 250mg

Octahydroindolizin-7-one, 95+%, 500mg

1,3,5-Cycloheptatriene>95.0%(GC)25mL

ethyl 8-[4-(4-methylpiperazinomethyl)phenyl]-8-oxooctanoate, 97.0%, 1g

Methyl 3-(hydroxymethyl)benzoate, 95.0%, 250mg

4-(4-Bromo-3-fluorobenzyl)thiomorpholine 1,1-dioxide, 97%, 5g

5-(2-Hydroxyethyl)-3,4-dimethylthiazol-3-ium iodide, 97.0%, 250mg

5-Bromo-2-nitrobenzotrifluoride, 98.0%, 1g

2-Fluoroisobutyric acid, 97.0%, 5g

Flacons à fond rond à trois cols cols latéraux parallèles, 2000 ml, 29/32, 29/32, 1 pièce

(S)-tetrahydropyridazine-1,2,3-tricarboxylic acid 1,2-di-tert-butyl ester, 98.0%, 5g

ethyl 4-(cyanosulfanyl)-5-(furan-2-amido)-3-methylthiophene-2-carboxylate, 95.0%, 500mg

Salicylic acid 4-tert-butylphenyl ester, 98%, 25g